EN
HI
Marksans Pharma Share price
MARKSANS
178.38
1.48 (0.84%)NSE
BSE
Last updated on 20 Feb, 2026 | 15:48 IST
BUYSELL
Today's High
179.52
Today's Low
175.46
52 Week Low
156.00
52 Week High
270.70
Free Demat with Zero AMC*
Marksans Pharma Chart
Marksans Pharma Share Key Metrics
Volume
4.38 L
Market Cap
8085.76 CR
LTQ@LTP
12@178.38
ATP
177.71
Var Margin
20.86 %
Circuit Range
141.52-212.28
Delivery %
56.34 %
Value
7.79 CR
ASM/GSM
No
Market Lot
1
Summary
At 20 Feb, 2026 | 15:48, Marksans Pharma share price stands at ₹178.38, showing a 1.48% 0.84 for the day. The stock’s intraday movement has stayed between ₹175.46 and ₹179.52, while on a 52-week basis it has fluctuated from ₹156.00 to ₹270.70.
In terms of trading activity, Marksans Pharma has recorded a volume of 438131 shares, with a market capitalisation of ₹453288438. The stock’s Average Traded Price (ATP) stands at ₹17771, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 12,17838. The stock operates within a circuit range of ₹141.52-212.28, with a Value of ₹7.79 CR. The Delivery Percentage for the day is 56.34%. Additionally, Marksans Pharma currently falls under the No framework, and trades with a market lot size of 1.
Marksans Pharma Fundamentals
View MoreP/E Ratio
22.26
P/B Ratio
2.86
Div. Yield
0.45
Sector P/E
63.82
Sector P/B
2.76
Sec. Div. Yield
0.57
Marksans Pharma Resistance and Support
Pivot 178.6
Resistance
First Resistance
181.09
Second Resistance
185.28
Third Resistance
187.77
Support
First Support
174.41
Second Support
171.92
Third Support
167.73
Marksans Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-05 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-19 | Audited Results & Final Dividend |
| 2025-02-11 | Quarterly Results |
Marksans Pharma News
Marksans Pharma stock skyrockets 13% on strong all-round Q1 earnings show
Aug 14 2024 12:31:54
Read More
About Marksans Pharma
NSE : 10579
BSE : 524404
ISIN : INE750C01026
Marksans Pharma Management
| Name | Position |
|---|---|
| Mr. Mark Saldanha | Chairman & Managing Director |
| Mrs. Sandra Saldanha | Whole Time Director |
Marksans Pharma Similar Stocks
Viyash Scientific Ltd.
217.34
1.62 (0.75%)
CORONA Remedies Ltd.
1524.10
-44.50 (2.84%)
Sanofi India Ltd.
4026.10
1.60 (0.04%)
Procter & Gamble Health Ltd.
5080.00
62.50 (1.25%)
Healthcare Global Enterprises Ltd.
588.60
-6.25 (1.05%)
Jupiter Life Line Hospitals Ltd.
1212.30
-19.70 (1.60%)
Strides Pharma Science Ltd.
869.65
-0.55 (0.06%)
Park Medi World Ltd.
184.37
0.13 (0.07%)
Akums Drugs & Pharmaceuticals Ltd.
478.35
-9.15 (1.88%)
Sudeep Pharma Ltd.
664.85
-6.15 (0.92%)
Marksans Pharma FAQs
The Buying Price of Marksans Pharma share is 178.38 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Marksans Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Marksans Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Marksans Pharma shares is 22.26. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Marksans Pharma shares is 2.86. Useful to assess the stock's value relative to its book value.
To assess Marksans Pharma’s valuation compare Sector P/E, P/B which are 63.82 & 2.76 with sector averages, along with growth rates and financial metrics.
The Market Cap of Marksans Pharma is 8085.76 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Marksans Pharma share price is 270.70 & 156.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Marksans Pharma belongs to the Healthcare sector.
